Investigation of Cannabinoid 2-receptor Expression in the Brain and Spine of ALS-patients Compared to Healthy Controls With PET (18F-RoSMALS)
Clinical trial NCT05880563 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05880563
- Sponsor
- Markus Weber
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2026-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.